NO20044105L - VEGF peptider og anvendelse derav - Google Patents

VEGF peptider og anvendelse derav

Info

Publication number
NO20044105L
NO20044105L NO20044105A NO20044105A NO20044105L NO 20044105 L NO20044105 L NO 20044105L NO 20044105 A NO20044105 A NO 20044105A NO 20044105 A NO20044105 A NO 20044105A NO 20044105 L NO20044105 L NO 20044105L
Authority
NO
Norway
Prior art keywords
vegf peptides
vegf
peptides
sckntdsrckarqlelnertcrcdkprr
fragment
Prior art date
Application number
NO20044105A
Other languages
English (en)
Norwegian (no)
Inventor
David Selwood
Ian Zachary
Marianne Loehr
Original Assignee
Ark Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Ltd filed Critical Ark Therapeutics Ltd
Publication of NO20044105L publication Critical patent/NO20044105L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20044105A 2002-04-02 2004-09-27 VEGF peptider og anvendelse derav NO20044105L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0207644.6A GB0207644D0 (en) 2002-04-02 2002-04-02 Peptides and their use
PCT/GB2003/001375 WO2003082918A1 (en) 2002-04-02 2003-03-28 Vegf peptides and their use

Publications (1)

Publication Number Publication Date
NO20044105L true NO20044105L (no) 2004-10-27

Family

ID=9934136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044105A NO20044105L (no) 2002-04-02 2004-09-27 VEGF peptider og anvendelse derav

Country Status (17)

Country Link
US (1) US20060166868A1 (ko)
EP (1) EP1490401B1 (ko)
JP (1) JP2005531527A (ko)
KR (1) KR100641535B1 (ko)
CN (1) CN1642979A (ko)
AT (1) ATE360644T1 (ko)
AU (1) AU2003226515B2 (ko)
CA (1) CA2481253A1 (ko)
DE (1) DE60313444T2 (ko)
ES (1) ES2283799T3 (ko)
GB (1) GB0207644D0 (ko)
IL (1) IL163799A0 (ko)
MX (1) MXPA04009479A (ko)
NO (1) NO20044105L (ko)
PL (1) PL371546A1 (ko)
WO (1) WO2003082918A1 (ko)
ZA (1) ZA200406922B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795213B2 (en) 2001-12-13 2010-09-14 Posco Methods of contacting β amyloid protein with VEGF
US7148199B2 (en) 2003-09-26 2006-12-12 University Of Florida Research Foundation, Inc. Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
CN1904150B (zh) * 2006-08-01 2010-07-28 华东师范大学 一种人胰高血糖素样肽-1衍生物及其固相化学合成
GB0619609D0 (en) * 2006-10-04 2006-11-15 Ark Therapeutics Ltd Compounds and their use
GB0619611D0 (en) * 2006-10-04 2006-11-15 Ark Therapeutics Ltd Compounds and their use
CN104774246B (zh) * 2014-03-21 2018-05-04 中山大学附属肿瘤医院 Nrp-1特异性肿瘤靶向多肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008473A1 (en) * 1991-10-24 1993-04-29 Beth Israel Hospital Association Assay for malignant effusions
CA2313390A1 (en) * 1997-12-09 1999-06-17 Children's Medical Center Corporation Peptide antagonists of vascular endothelial growth factor
US7045133B2 (en) * 2000-01-18 2006-05-16 Ludwig Institute For Cancer Research VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor

Also Published As

Publication number Publication date
GB0207644D0 (en) 2002-05-15
PL371546A1 (en) 2005-06-27
ATE360644T1 (de) 2007-05-15
CN1642979A (zh) 2005-07-20
IL163799A0 (en) 2005-12-18
ZA200406922B (en) 2006-06-28
US20060166868A1 (en) 2006-07-27
AU2003226515B2 (en) 2006-06-08
JP2005531527A (ja) 2005-10-20
DE60313444T2 (de) 2007-08-30
KR20040099356A (ko) 2004-11-26
CA2481253A1 (en) 2003-10-09
EP1490401A1 (en) 2004-12-29
WO2003082918A1 (en) 2003-10-09
MXPA04009479A (es) 2005-01-25
KR100641535B1 (ko) 2006-10-31
DE60313444D1 (de) 2007-06-06
ES2283799T3 (es) 2007-11-01
EP1490401B1 (en) 2007-04-25
AU2003226515A1 (en) 2003-10-13

Similar Documents

Publication Publication Date Title
ATE482972T1 (de) Tgf-beta1-bindende und geträgerte peptide
AU2003228809A8 (en) Kinase anchor protein muteins, peptides thereof, and related methods
ATE368853T1 (de) Zell-selektives abgabe system
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE602004011770D1 (de) Fusionsproteine
PT1171465E (pt) Analogos de petido inibidor gastrico e sua utilizacao para o tratamento de diabetes
CY1112330T1 (el) Πρωτεϊνες συνδεσης gag
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
NO20063026L (no) Antistoffer
ATE460176T1 (de) Mikrosomvakzin
DE69533704D1 (de) Bradykinin-antagonist peptide mit n-substituierten glycinen
CY1108599T1 (el) Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος
NO20044105L (no) VEGF peptider og anvendelse derav
ATE489401T1 (de) Pegyliertes t20-polypeptid
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
NO20040880L (no) Casein avledete peptider og anvendelser derav i terapi.
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
DE69932834D1 (de) Chi-Conotoxinpeptide als Inhibitoren neuronaler Amintransporter
ATE554102T1 (de) Therapeutische verwendungen von monoklonalen antikörpern gegen den angiotensin-ii typ-1 rezeptor
ATE312077T1 (de) Peptiddeformylase-hemmer
NO20082864L (no) Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav
NO20044186L (no) Peptid-deformylaseinhibitorer
DE602004032379D1 (de) Prozessierung von peptiden und proteinen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application